Annual Retained Earnings
-$1.19 B
-$252.85 M-27.01%
December 31, 2023
Summary
- As of February 10, 2025, ACOR annual retained earnings is -$1.19 billion, with the most recent change of -$252.85 million (-27.01%) on December 31, 2023.
- During the last 3 years, ACOR annual retained earnings has fallen by -$422.72 million (-55.16%).
Performance
ACOR Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Retained Earnings
-$1.22 B
-$27.39 M-2.30%
March 31, 2024
Summary
- As of February 10, 2025, ACOR quarterly retained earnings is -$1.22 billion, with the most recent change of -$27.39 million (-2.30%) on March 31, 2024.
- Over the past year, ACOR quarterly retained earnings has dropped by -$263.43 million (-27.64%).
Performance
ACOR Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ACOR Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.0% | -27.6% |
| 3 y3 years | -55.2% | -52.1% |
| 5 y5 years | -201.9% | -175.6% |
ACOR Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +36.6% | at low | +39.8% | at low |
| 5 y | 5-year | +78.3% | at low | +82.4% | at low |
| alltime | all time | +1205.9% | at low | +964.5% | at low |
Acorda Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | -$1.22 B(+2.3%) |
| Dec 2023 | -$1.19 B(+27.0%) | -$1.19 B(+22.4%) |
| Sep 2023 | - | -$971.37 M(+0.9%) |
| Jun 2023 | - | -$962.48 M(+1.0%) |
| Mar 2023 | - | -$953.10 M(+1.8%) |
| Dec 2022 | -$936.27 M(+7.6%) | -$936.27 M(-2.0%) |
| Sep 2022 | - | -$955.41 M(+1.5%) |
| Jun 2022 | - | -$941.56 M(+5.2%) |
| Mar 2022 | - | -$894.88 M(+2.8%) |
| Dec 2021 | -$870.36 M(+13.6%) | -$870.36 M(+2.4%) |
| Sep 2021 | - | -$849.79 M(+3.3%) |
| Jun 2021 | - | -$822.72 M(+2.9%) |
| Mar 2021 | - | -$799.86 M(+4.4%) |
| Dec 2020 | -$766.40 M(+14.9%) | -$766.40 M(+12.2%) |
| Sep 2020 | - | -$683.36 M(-1.1%) |
| Jun 2020 | - | -$690.70 M(+2.6%) |
| Mar 2020 | - | -$673.28 M(+1.0%) |
| Dec 2019 | -$666.81 M(+69.3%) | -$666.81 M(-9.0%) |
| Sep 2019 | - | -$732.47 M(+56.2%) |
| Jun 2019 | - | -$468.93 M(+6.2%) |
| Mar 2019 | - | -$441.45 M(+12.1%) |
| Dec 2018 | -$393.84 M(-13.5%) | -$393.84 M(-2.4%) |
| Sep 2018 | - | -$403.44 M(+3.6%) |
| Jun 2018 | - | -$389.53 M(-10.6%) |
| Mar 2018 | - | -$435.73 M(-4.3%) |
| Dec 2017 | -$455.11 M(+86.5%) | -$455.11 M(+60.2%) |
| Sep 2017 | - | -$284.15 M(+9.7%) |
| Jun 2017 | - | -$258.95 M(+3.3%) |
| Mar 2017 | - | -$250.76 M(+2.8%) |
| Dec 2016 | -$243.97 M(+16.5%) | -$243.97 M(+1.3%) |
| Sep 2016 | - | -$240.88 M(+5.6%) |
| Jun 2016 | - | -$228.15 M(+8.7%) |
| Mar 2016 | - | -$209.87 M(+0.2%) |
| Dec 2015 | -$209.35 M(-5.0%) | -$209.35 M(-4.2%) |
| Sep 2015 | - | -$218.56 M(-1.8%) |
| Jun 2015 | - | -$222.50 M(-0.4%) |
| Mar 2015 | - | -$223.50 M(+1.4%) |
| Dec 2014 | -$220.41 M | -$220.41 M(-0.1%) |
| Sep 2014 | - | -$220.74 M(-5.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | -$232.69 M(-2.0%) |
| Mar 2014 | - | -$237.38 M(-0.3%) |
| Dec 2013 | -$238.08 M(-6.5%) | -$238.08 M(-2.5%) |
| Sep 2013 | - | -$244.27 M(-3.0%) |
| Jun 2013 | - | -$251.75 M(-1.5%) |
| Mar 2013 | - | -$255.66 M(+0.4%) |
| Dec 2012 | -$254.52 M(-37.8%) | -$254.52 M(-34.3%) |
| Sep 2012 | - | -$387.50 M(-2.4%) |
| Jun 2012 | - | -$397.09 M(-1.1%) |
| Mar 2012 | - | -$401.63 M(-1.9%) |
| Dec 2011 | -$409.48 M(-7.0%) | -$409.48 M(-3.0%) |
| Sep 2011 | - | -$422.18 M(-4.3%) |
| Jun 2011 | - | -$441.04 M(+0.1%) |
| Mar 2011 | - | -$440.76 M(+0.2%) |
| Dec 2010 | -$440.09 M(+2.7%) | -$440.09 M(-0.8%) |
| Sep 2010 | - | -$443.76 M(-2.7%) |
| Jun 2010 | - | -$456.19 M(+1.5%) |
| Mar 2010 | - | -$449.43 M(+4.9%) |
| Dec 2009 | -$428.32 M(+24.4%) | -$428.32 M(+5.5%) |
| Sep 2009 | - | -$405.84 M(+5.0%) |
| Jun 2009 | - | -$386.41 M(+6.4%) |
| Mar 2009 | - | -$363.08 M(+5.4%) |
| Dec 2008 | -$344.38 M(+27.5%) | -$344.38 M(+6.2%) |
| Sep 2008 | - | -$324.14 M(+6.2%) |
| Jun 2008 | - | -$305.29 M(+6.6%) |
| Mar 2008 | - | -$286.47 M(+6.1%) |
| Dec 2007 | -$270.04 M(+16.4%) | -$270.04 M(+5.4%) |
| Sep 2007 | - | -$256.31 M(+3.4%) |
| Jun 2007 | - | -$247.77 M(+3.4%) |
| Mar 2007 | - | -$239.61 M(+3.3%) |
| Dec 2006 | -$232.06 M(+11.5%) | -$232.06 M(+3.1%) |
| Sep 2006 | - | -$225.05 M(+3.3%) |
| Jun 2006 | - | -$217.88 M(+1.3%) |
| Mar 2006 | - | -$214.99 M(+3.3%) |
| Dec 2005 | -$208.04 M(+20.6%) | -$208.04 M(+4.8%) |
| Sep 2005 | - | -$198.48 M(+73.7%) |
| Dec 2004 | -$172.51 M(+89.5%) | - |
| Sep 2003 | - | -$114.28 M |
| Jun 2003 | -$91.06 M | - |
FAQ
- What is Acorda Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Acorda Therapeutics?
- What is Acorda Therapeutics annual retained earnings year-on-year change?
- What is Acorda Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Acorda Therapeutics?
- What is Acorda Therapeutics quarterly retained earnings year-on-year change?
What is Acorda Therapeutics annual retained earnings?
The current annual retained earnings of ACOR is -$1.19 B
What is the all time high annual retained earnings for Acorda Therapeutics?
Acorda Therapeutics all-time high annual retained earnings is -$91.06 M
What is Acorda Therapeutics annual retained earnings year-on-year change?
Over the past year, ACOR annual retained earnings has changed by -$252.85 M (-27.01%)
What is Acorda Therapeutics quarterly retained earnings?
The current quarterly retained earnings of ACOR is -$1.22 B
What is the all time high quarterly retained earnings for Acorda Therapeutics?
Acorda Therapeutics all-time high quarterly retained earnings is -$114.28 M
What is Acorda Therapeutics quarterly retained earnings year-on-year change?
Over the past year, ACOR quarterly retained earnings has changed by -$263.43 M (-27.64%)